Table:
begin	end	state
1	26	signal peptide
27	40	non-cytoplasmic
41	64	transmembrane
65	74	cytoplasmic
75	94	transmembrane
95	95	non-cytoplasmic
96	119	transmembrane
120	130	cytoplasmic
131	148	transmembrane
149	164	non-cytoplasmic
165	192	transmembrane
193	206	cytoplasmic
207	228	transmembrane
229	232	non-cytoplasmic
233	252	transmembrane
253	256	cytoplasmic
257	296	transmembrane
297	313	non-cytoplasmic
314	335	transmembrane
336	352	cytoplasmic
353	384	transmembrane
385	395	non-cytoplasmic
396	422	transmembrane
423	433	cytoplasmic
434	434	non-cytoplasmic
435	460	transmembrane
461	468	non-cytoplasmic

Input:
>SM_b20444 FitnessBrowser__Smeli:SM_b20444
MLLLVGSFLVLMLVGVPVAISMAAASVLYLVSYNVAPDIIAAQRMIAGVESFPLLAVPFF
ILAGNLMNSAGVTGRIYSFAVALVGWMKGGLAQVNIVGSVIFSGMSGTALADAAGIGTIE
IKAMKDHGYPVDAAVGVTAASATLGPIFPPSLPFVIYGMMANVSIGALFMAGVVPGVVMT
VLMMLTVAIFAYKRGWGSDTPFEMKRLLAASLEVVVVLAVPLFIYLLMAAGLSMNLAVGI
ALVVLLALDWYFDFSAVMALMTPIILIGGMTMGWFTPTEAAVAAVIWSLFLGLVRYRTMT
MSTLARATFDTIETTASVLFIVTAASIFAWLLTVSQAAQMLSGAILTITDNKWVFLILVN
LLMLFVGCFLDTIAAITILVPILLPLTAQFGIDPVHFGLIMTLNLMIGLLHPPLGMVLFV
LSRVAKLSVERTTMAILPWLVPLFIALILITFVPAVVLWLPQSVGLIR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server